Hydroxyapatite (HA), a calcium phosphate compound naturally found in bones and teeth, is emerging as a game-changer in the fields of medicine and pharmaceuticals. A recent systematic literature review with bibliometric analysis highlights HA’s powerful role as a delivery and carrier material, offering new opportunities for drug delivery, tissue regeneration, and personalized therapies.
Researchers found that HA’s unique properties make it highly biocompatible and versatile. It not only allows for controlled drug release but also supports targeted therapies and promotes tissue healing. This means doctors and scientists could use HA-based systems to improve how medicines are delivered in the body, making treatments more effective while minimizing side effects.
The review also reveals exciting trends in HA research, such as advances in synthesis and modification methods that tailor drug release to patient needs. By combining these innovations with HA’s natural compatibility with the human body, scientists are moving closer to developing smarter, safer, and more efficient therapeutic strategies.
The findings connect closely with Sustainable Development Goal (SDG) 3: Good Health and Well-being, as HA-based technologies can contribute to better healthcare access, improved patient outcomes, and more personalized medical treatments.
In conclusion, Hydroxyapatite holds enormous promise for revolutionizing modern medicine. With continued research and innovation, it could pave the way for a future where healthcare is not only more effective but also tailored to each patient’s needs.
Source: https://ejournal.upi.edu/index.php/AJSE/article/view/70223
Kim-07/24
